Recommended Pages at pfizer.mediaroom.com
Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older - Dec 22, 2010
pfizer.mediaroom.com — “Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older - Dec 22, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on December 22, 2010 at 7:50 pm By:
Pfizer submits applications to FDA and EMA for use of its pneumococcal conjugate vaccine in adults 50 and older: http://bit.ly/g6Z07K
News Release Archive - News Releases
pfizer.mediaroom.com — “News Release Archive - News Releases” View full resource at pfizer.mediaroom.com
Most Recently Shared on December 15, 2010 at 10:39 pm By:
Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc. http://bit.ly/f9lHqF
Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman - Dec 13, 2010
pfizer.mediaroom.com — “Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman - Dec 13, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on December 13, 2010 at 9:34 pm By:
Pfizer Board Of Directors elects George A. Lorch Non-Executive Chairman http://bit.ly/eXczfE
Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine - Dec 12, 2010
pfizer.mediaroom.com — “Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine - Dec 12, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on December 12, 2010 at 3:47 pm By:
Young children in Developing World receive accelerated access to Pfizer’s Prevenar 13 vaccine http://bit.ly/glAVtQ
Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety - Dec 10, 2010
pfizer.mediaroom.com — “Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety - Dec 10, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on December 10, 2010 at 1:06 pm By:
Pfizer stops clinical trials of Thelin® and initiates voluntary product withdrawal in the interest of patient safety http://bit.ly/eDcfeT
Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC) - Nov 19, 2010
pfizer.mediaroom.com — “Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC) - Nov 19, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on November 19, 2010 at 5:20 pm By:
Check out this latest Pfizer press release: http://bit.ly/aWolpS
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and Burden of Alzheimer's Disease - Nov 9, 2010
pfizer.mediaroom.com — “Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and Burden of Alzheimer's Disease - Nov 9, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on November 9, 2010 at 2:09 pm By:
Alpine Mountaineer & Alzheimer’s Advocate to climb highest peak on each continent to raise awareness...http://bit.ly/aufZj0
In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function - Nov 7, 2010
pfizer.mediaroom.com — “In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function - Nov 7, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on November 7, 2010 at 10:08 pm By:
Press Release: In First Phase 3 Trial...http://bit.ly/c9aVVz
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference - Nov 3, 2010
pfizer.mediaroom.com — “Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference - Nov 3, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on November 3, 2010 at 7:10 pm By:
Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference http://bit.ly/aDtHzU
Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066) - Oct 27, 2010
pfizer.mediaroom.com — “Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066) - Oct 27, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on October 27, 2010 at 9:59 pm By:
Results From An Expanded Cohort Phase 1 Study Published In The New England Journal http://bit.ly/9xyIto
Biocon and Pfizer Enter Into Global Commercialization Agreement - Oct 18, 2010
pfizer.mediaroom.com — “Biocon and Pfizer Enter Into Global Commercialization Agreement - Oct 18, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on October 18, 2010 at 11:28 am By:
Biocon and Pfizer enter into Global Commercialization Agreement http://bit.ly/9mXNtX
Pfizer to Acquire King Pharmaceuticals, Inc. - Oct 12, 2010
pfizer.mediaroom.com — “Pfizer to Acquire King Pharmaceuticals, Inc. - Oct 12, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on October 12, 2010 at 12:04 pm By:
Pfizer to acquire King Pharmaceuticals, Inc. http://bit.ly/cd1qhU
Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets - Oct 7, 2010
pfizer.mediaroom.com — “Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets - Oct 7, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on October 7, 2010 at 10:05 am By:
Pfizer #Oncology to present new clinical data across ten tumor types and multiple molecular targets at ESMO http://bit.ly/c6nJta
Pfizer To Review Strategic Alternatives For Capsugel - Oct 6, 2010
pfizer.mediaroom.com — “Pfizer To Review Strategic Alternatives For Capsugel - Oct 6, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on October 6, 2010 at 4:12 pm By:
Pfizer to review strategic alternatives for Capsugel http://bit.ly/cui4SK
Pfizer Offers First 500,000 Consumers Free Advil to Launch Medicine Cabinet Cleanout Campaign - Oct 4, 2010
pfizer.mediaroom.com — “Pfizer Offers First 500,000 Consumers Free Advil to Launch Medicine Cabinet Cleanout Campaign - Oct 4, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on October 4, 2010 at 6:10 pm By:
Pfizer offers first 500,000 consumers free Advil® to launch medicine cabinet cleanout campaign http://bit.ly/ddu1Ri
